These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19468997)

  • 41. Enteropathic spondyloarthropathy: a common genetic background with inflammatory bowel disease?
    Colombo E; Latiano A; Palmieri O; Bossa F; Andriulli A; Annese V
    World J Gastroenterol; 2009 May; 15(20):2456-62. PubMed ID: 19468994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mucosal T cell proliferation and apoptosis in inflammatory bowel disease.
    Sturm A; de Souza HS; Fiocchi C
    Curr Drug Targets; 2008 May; 9(5):381-7. PubMed ID: 18473766
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Joint involvement associated with inflammatory bowel disease.
    De Vos M
    Dig Dis; 2009; 27(4):511-5. PubMed ID: 19897967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evidence for the prevention of enthesitis in HLA-B27/hβ(2)m transgenic rats treated with a monoclonal antibody against TNF-α.
    Milia AF; Ibba-Manneschi L; Manetti M; Benelli G; Generini S; Messerini L; Matucci-Cerinic M
    J Cell Mol Med; 2011 Feb; 15(2):270-9. PubMed ID: 20015205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association.
    de Vlam K; Mielants H; Cuvelier C; De Keyser F; Veys EM; De Vos M
    J Rheumatol; 2000 Dec; 27(12):2860-5. PubMed ID: 11128677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.
    Breban M; Tap J; Leboime A; Said-Nahal R; Langella P; Chiocchia G; Furet JP; Sokol H
    Ann Rheum Dis; 2017 Sep; 76(9):1614-1622. PubMed ID: 28606969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alteration of antigen-independent immunologic synapse formation between dendritic cells from HLA-B27-transgenic rats and CD4+ T cells: selective impairment of costimulatory molecule engagement by mature HLA-B27.
    Hacquard-Bouder C; Chimenti MS; Giquel B; Donnadieu E; Fert I; Schmitt A; André C; Breban M
    Arthritis Rheum; 2007 May; 56(5):1478-89. PubMed ID: 17469106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician.
    Lubrano E; Luchetti MM; Benfaremo D; Mauro D; Ciccia F; Perrotta FM
    Expert Rev Clin Immunol; 2021 Nov; 17(11):1199-1209. PubMed ID: 34622735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2273-8. PubMed ID: 8835561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The histopathology of spondyloarthropathy.
    Baeten D; De Keyser F
    Curr Mol Med; 2004 Feb; 4(1):1-12. PubMed ID: 15011954
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A cross-sectional study of 130 Brazilian patients with Crohn's disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations.
    Lanna CC; Ferrari Mde L; Rocha SL; Nascimento E; de Carvalho MA; da Cunha AS
    Clin Rheumatol; 2008 Apr; 27(4):503-9. PubMed ID: 18097711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ulcerative colitis, seronegative spondyloarthropathies and allergic diseases: the search for a link.
    D'Arienzo A; Manguso F; Scarpa R; Astarita C; D'Armiento FP; Bennato R; Gargano D; Sanges M; Mazzacca G
    Scand J Gastroenterol; 2002 Oct; 37(10):1156-63. PubMed ID: 12408520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue.
    Rysnik O; McHugh K; van Duivenvoorde L; van Tok M; Guggino G; Taurog J; Kollnberger S; Ciccia F; Baeten D; Bowness P
    J Autoimmun; 2016 Jun; 70():12-21. PubMed ID: 27036372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease.
    Adams DH; Eksteen B
    Nat Rev Immunol; 2006 Mar; 6(3):244-51. PubMed ID: 16498453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rheumatic manifestations in inflammatory bowel disease.
    Atzeni F; Defendenti C; Ditto MC; Batticciotto A; Ventura D; Antivalle M; Ardizzone S; Sarzi-Puttini P
    Autoimmun Rev; 2014 Jan; 13(1):20-3. PubMed ID: 23774109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting T and B lymphocytes in inflammatory bowel diseases: lessons from clinical trials.
    Gerner RR; Moschen AR; Tilg H
    Dig Dis; 2013; 31(3-4):328-35. PubMed ID: 24246983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Putative Pathobionts in HLA-B27-Associated Spondyloarthropathy.
    Gill T; Rosenbaum JT
    Front Immunol; 2020; 11():586494. PubMed ID: 33537028
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Defective costimulatory function is a striking feature of antigen-presenting cells in an HLA-B27-transgenic rat model of spondylarthropathy.
    Hacquard-Bouder C; Falgarone G; Bosquet A; Smaoui F; Monnet D; Ittah M; Breban M
    Arthritis Rheum; 2004 May; 50(5):1624-35. PubMed ID: 15146433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.